Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial

Orla M Smith, Ron Wald, Neill K J Adhikari, Karen Pope, Matthew A Weir, Sean M Bagshaw, Canadian Critical Care Trials Group, François Lamontagne, Jean-François Bilodeau, Chantal Langevin, Kim Meunier, Matthew Weir, Laura Webster, Andrew House, Matthew Weir, Amit Garg, Claudio Martin, Ravi Taneja, Virginia Schumann, Farrah Tuffin, Stephen Lapinsky, Maedean Brown, Rottem Kuint, Mark Soth, Deborah Cook, Michael Walsh, France Clarke, Nicole Zytaruk, Ron Wald, Karen Burns, Jan Friedrich, David Klein, David Mazer, Orla Smith, Julia Lee, Melissa Wang, Sanjay Yagnik, Neill K J Adhikari, Michelle Hladunewich, Nicole Marinoff, Lauralyn McIntyre, Swapnil Hiremath, Tracy McArdle, Shawna Reddie, Lauralyn McIntyre, Ted Clark, Swapnil Hiremath, Rebecca Porteous, Irene Watpool, Amanda van Beinum, Sean Bagshaw, Constantine Karvellas, Noel Gibney, Samantha Taylor, Nadia Baig, Margaret Herridge, Bob Richardson, Paulina Farias, Andrea Matte, Stefannie Vorona, Margaret Herridge, Bob Richardson, Paulina Farias, Harrison Brown, Orla M Smith, Ron Wald, Neill K J Adhikari, Karen Pope, Matthew A Weir, Sean M Bagshaw, Canadian Critical Care Trials Group, François Lamontagne, Jean-François Bilodeau, Chantal Langevin, Kim Meunier, Matthew Weir, Laura Webster, Andrew House, Matthew Weir, Amit Garg, Claudio Martin, Ravi Taneja, Virginia Schumann, Farrah Tuffin, Stephen Lapinsky, Maedean Brown, Rottem Kuint, Mark Soth, Deborah Cook, Michael Walsh, France Clarke, Nicole Zytaruk, Ron Wald, Karen Burns, Jan Friedrich, David Klein, David Mazer, Orla Smith, Julia Lee, Melissa Wang, Sanjay Yagnik, Neill K J Adhikari, Michelle Hladunewich, Nicole Marinoff, Lauralyn McIntyre, Swapnil Hiremath, Tracy McArdle, Shawna Reddie, Lauralyn McIntyre, Ted Clark, Swapnil Hiremath, Rebecca Porteous, Irene Watpool, Amanda van Beinum, Sean Bagshaw, Constantine Karvellas, Noel Gibney, Samantha Taylor, Nadia Baig, Margaret Herridge, Bob Richardson, Paulina Farias, Andrea Matte, Stefannie Vorona, Margaret Herridge, Bob Richardson, Paulina Farias, Harrison Brown

Abstract

Background: Acute kidney injury is a common and devastating complication of critical illness, for which renal replacement therapy is frequently needed to manage severe cases. While a recent systematic review suggested that "earlier" initiation of renal replacement therapy improves survival, completed trials are limited due to small size, single-centre status, and use of variable definitions to define "early" renal replacement therapy initiation.

Methods/design: This is an open-label pilot randomized controlled trial. One hundred critically ill patients with severe acute kidney injury will be randomly allocated 1:1 to receive "accelerated" initiation of renal replacement therapy or "standard" initiation at 12 centers across Canada. In the accelerated arm, participants will have a venous catheter placed and renal replacement therapy will be initiated within 12 hours of fulfilling eligibility. In the standard initiation arm, participants will be monitored over 7 days to identify indications for renal replacement therapy. For participants in the standard arm with persistent acute kidney injury, defined as a serum creatinine not declining >50% from the value at the time of eligibility, the initiation of RRT will be discouraged unless one or more of the following criteria are fulfilled: serum potassium ≥6.0 mmol/L; serum bicarbonate ≤10 mmol/L; severe respiratory failure (PaO₂/FiO₂<200) or persisting acute kidney injury for ≥72 hours after fulfilling eligibility. The inclusion criteria are designed to identify a population of critically ill adults with severe acute kidney injury who are likely to need renal replacement therapy during their hospitalization, but not immediately. The primary outcome is protocol adherence (>90%). Secondary outcomes include measures of feasibility (proportion of eligible patients enrolled in the trial, proportion of enrolled patients followed to 90 days for assessment of vital status and the need for renal replacement therapy) and safety (occurrence of adverse events).

Discussion: The optimal timing of renal replacement therapy initiation in patients with severe acute kidney injury remains uncertain, representing an important knowledge gap and a priority for high-quality research. This pilot trial is necessary to establish protocol feasibility, confirm the safety of participants and obtain estimated events rates for design of a large definitive trial.

Trial registration number: NCT01557361.

References

    1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–818. doi: 10.1001/jama.294.7.813.
    1. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9:R700–R709. doi: 10.1186/cc3879.
    1. Ahlstrom A, Tallgren M, Peltonen S, Rasanen P, Pettila V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31:1222–1228. doi: 10.1007/s00134-005-2681-6.
    1. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009;302:1179–1185. doi: 10.1001/jama.2009.1322.
    1. Overberger P, Pesacreta M, Palevsky PM. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am SocNephrol. 2007;2:623–630. doi: 10.2215/CJN.00780207.
    1. Ricci Z, Ronco C, D’Amico G, De Felice R, Rossi S, Bolgan I, Bonello M, Zamperetti N, Petras D, Salvatori G, Dan M, Piccinni P. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21:690–696. doi: 10.1093/ndt/gfi296.
    1. Klarenbach S, Manns B, Pannu N, Clement FM, Wiebe N, Tonelli M. Economic evaluation of continuous renal replacement therapy in acute renal failure. Int J Technol Assess Health Care. 2009;25:331–338. doi: 10.1017/S0266462309990134.
    1. Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care. 2010;14:R46. doi: 10.1186/cc8933.
    1. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363:609–619. doi: 10.1056/NEJMoa1000552.
    1. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15:R72. doi: 10.1186/cc10061.
    1. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205–2211. doi: 10.1097/00003246-200210000-00005.
    1. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–1638.
    1. Kellum JA, Mehta RL, Levin A, Molitoris BA, Warnock DG, Shah SV, Joannidis M, Ronco C. Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am SocNephrol. 2008;3:887–894. doi: 10.2215/CJN.04891107.
    1. Clark E, Wald R, Walsh M, Bagshaw SM. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant. 2012;27:2761–2767. doi: 10.1093/ndt/gfr740.
    1. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238. doi: 10.1016/S0140-6736(05)74811-X.
    1. Cruz DN, de Geus HR, Bagshaw SM. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial. 2011;24:124–131. doi: 10.1111/j.1525-139X.2011.00830.x.
    1. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson K, Milzman D, Gaieski DF, Goyal M, Cairns CB, Kupfer K, Lee SW, Rivers EP. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med. 2010;56:52–59. doi: 10.1016/j.annemergmed.2010.02.010. e51.
    1. Nickolas TL, O’Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148:810–819. doi: 10.7326/0003-4819-148-11-200806030-00003.
    1. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54:1012–1024. doi: 10.1053/j.ajkd.2009.07.020.
    1. de Geus HR, Bakker J, Lesaffre EM, le Noble JL. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J RespirCrit Care Med. 2011;183:907–914. doi: 10.1164/rccm.200908-1214OC.
    1. Srisawat N, Murugan R, Lee M, Kong L, Carter M, Angus DC, Kellum JA. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int. 2011;80:545–552. doi: 10.1038/ki.2011.160.
    1. Cook DJ, Blythe D, Rischbieth A, Hebert PC, Zytaruk N, Menon K, Erikson S, Fowler R, Heels-Ansdell D, Meade MO. Enrollment of intensive care unit patients into clinical studies: a trinational survey of researchers’ experiences, beliefs, and practices. Crit Care Med. 2008;36:2100–2105. doi: 10.1097/CCM.0b013e31817c00b0.
    1. Disease K. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012;2(Suppl):1–138.
    1. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart K, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707–710. doi: 10.1007/BF01709751.
    1. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20.
    1. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24:129–140. doi: 10.1016/j.jcrc.2007.12.017.
    1. Bagshaw SM, Wald R, Barton J, Burns KE, Friedrich JO, House AA, James MT, Levin A, Moist L, Pannu N, Stollery DE, Walsh MW. Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational study. J Crit Care. 2012;27:268–275. doi: 10.1016/j.jcrc.2011.06.003.
    1. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999;25:805–813. doi: 10.1007/s001340050956.
    1. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am SocNephrol. 2006;1:915–919. doi: 10.2215/CJN.01430406.
    1. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis. 2008;52:272–284. doi: 10.1053/j.ajkd.2008.02.371.
    1. Clark E, Wald R, Levin A, Bouchard J, Adhikari NK, Hladunewich M, Richardson RM, James MT, Walsh MW, House AA, Moist L, Stollery DE, Burns KE, Friedrich JO, Barton J, Lafrance JP, Pannu N, Bagshaw SM. Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Can J Anaesth. 2012;59:861–870. doi: 10.1007/s12630-012-9750-4.
    1. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259–265. doi: 10.1097/CCM.0b013e3181feeb15.
    1. Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16:R146. doi: 10.1186/cc11458.
    1. Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK. High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med. 2010;38:1360–1369.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться